Health Care & Life Sciences » Healthcare Provision | Venn Life Sciences Holdings PLC

Venn Life Sciences Holdings PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
1,728.40
3,933.70
8,328.10
14,682.30
15,244.10
Cost of Goods Sold (COGS) incl. D&A
-
-
8,510.30
15,314.40
15,535.80
Gross Income
-
-
182.20
632.10
291.70
SG&A Expense
3,078.10
5,303.20
-
-
-
EBIT
1,376.80
1,520.10
182.20
-
291.70
Unusual Expense
99.40
37.90
151.70
102.50
787.40
Non Operating Income/Expense
47.60
134.50
127.00
274.60
359.10
Interest Expense
34.80
57.20
31.90
-
-
Pretax Income
1,548.40
1,473.40
237.30
450.10
719.90
Income Tax
19.50
16.10
90.70
138.60
111.20
Equity in Affiliates
-
-
-
298.40
738.30
Consolidated Net Income
1,528.80
1,457.30
146.60
610.00
1,347.10
Net Income
1,528.80
1,235.00
10.90
594.40
1,347.10
Net Income After Extraordinaries
1,528.80
1,235.00
10.90
1,656.10
1,347.10
Net Income Available to Common
1,528.80
1,235.00
10.90
467.30
1,347.10
EPS (Basic)
0.08
0.05
0.00
0.01
0.02
Basic Shares Outstanding
-
-
-
-
60,284.30
EPS (Diluted)
-
-
-
-
0.02
Diluted Shares Outstanding
-
-
-
-
60,284.30
EBITDA
1,349.60
1,369.50
154.60
41.80
488.70
Non-Operating Interest Income
10.20
7.30
1.50
9.80
-
Minority Interest Expense
-
222.30
157.50
15.60
-

About Venn Life Sciences Holdings

View Profile
Address
19 Railway Road
Dublin Dublin
Ireland
Employees -
Website http://www.vennlifesciences.com
Updated 09/14/2018
Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company is headquartered in Dublin, Ireland.